Get Flat 15% Discount on ED Drugs for orders value $70 or more
  • Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      Drug regulator keen on USFDA tie-up for trials, medical-devices


      New Delhi, Aug 8 National health watchdog Drug Controller General of India is seeking co-operation from US Food and Drug Administrator for effective regulation, particularly for medical devices and clinical trials in the country.

      “We have identified five areas for co-operation with the US FDA, which includes new drugs, medical devices, clinical trials, pharmacology and IT and IT-enable services (in healthcare),” Drug Controller General of India (DCGI) Surinder Singh said.

      He said DCGI sought help of the USFDA particularly for medical devices and clinical trials, as there was already a system in place for the rest of the areas. As per the discussions held between DCGI and its counterpart, experts from the USFDA would hold workshops and training sessions in the country for Indian inspectors to help them in better monitoring of the healthcare industry.

      “Experts from US authorities have agreed to come here and would train our people in the field of inspecting and auditing medical devices and clinical trial sector,” he added.

      Medical devices, according to the definition of Indian government are considered as Drug and are put under the same regulations as for the medicines.

      The government with the help from USFDA is working on bringing guidelines for the sector according to the global standards, which according to the experts in the industry would be helpful in boosting exports also.

      USFDA would also help DCGI in better monitoring of clinical trials in the country as till now government's role was limited only in providing licenses and scrutinising data for the clinical trials in the country.

      August 14, 2008


      Share this Article!

    Back to top^